oral human papillomavirus – Oral Cancer News

Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study

Source: The LancetPublished: September 7, 2013By: Aimée R Kreimer PhD, Christine M Pierce Campbell PhD, Hui-Yi Lin PhD, William Fulp MS, Mary R Papenfuss MS, Martha Abrahamsen MPH, Prof Allan Hildesheim PhD, Prof Luisa L Villa PhD, Jorge J Salmerón MD, Prof Eduardo Lazcano-Ponce PhD, Prof Anna R Giuliano PhD Summary Background Oral human papillomavirus (HPV) infection causes a subset of oropharyngeal cancers. These cancers disproportionately affect men, are increasing in incidence, and have no proven prevention methods. We aimed to establish the natural history of oral HPV infection in men. Methods To estimate incidence and clearance of HPV infections, men residing in Brazil, Mexico, and the USA who were HIV negative and reported no history of anogenital cancer were recruited into the HPV Infection in Men (HIM) cohort study. A subset of the cohort who provided two or more oral rinse-and-gargle samples with valid HPV results and who completed a minimum of 2 weeks of follow-up were included in this analysis. Oral rinse-and-gargle samples and questionnaire data were obtained every 6 months for up to 4 years. Samples were analysed for the presence of oncogenic and non-oncogenic HPV infections by the linear array method. Findings 1626 men aged 18—73 years and with a median follow-up of 12·7 months (IQR 12·1—14·7) were included in the analysis. During the first 12 months of follow-up, 4·4% (95% CI 3·5—5·6; n=115 incident infections) of men acquired an incident oral HPV infection, 1·7% (1·2—2·5; n=53 incident infections) an oral oncogenic HPV infection, and 0·6% (0·3—1·1; [...]

Charlotte Parker2013-11-08T12:50:43-07:00November, 2013|Oral Cancer News|

Incidence of oral human papillomavirus infection

Source: The LancetPublished: November 9, 2013By: Zoe R. Edelstein, Stephen Schwartz, Laura A. Koutsky Aimée Kreimer and colleagues (Sept 7, p 877)1 report an annual incidence of oral human papillomavirus (HPV) infection of 4·4% in an international cohort of men (aged 18—73 years; n=1626; specimen collection every 6 months). We would like to offer a methodological explanation for the difference between this estimate and our estimate of 12·3% from a cohort in Seattle, WA, USA (aged 18—24 years; n=212; specimen collection every 4 months).2 There are several potential explanations, including differences in study population, sample size, and specimen collection schedule. We suggest that one of the main reasons is the difference in specimen collection method. Kreimer and colleagues measured HPV DNA using an oral rinse and gargle, whereas we used both an oral rinse and gargle and a self-collected swab of the back of the throat. In our paper, we also reported an incidence of 6·3% of oral HPV infection on the basis of the rinse-and-gargle method alone, which is closer to the 4·4% reported by Kreimer and colleagues. Pickard and colleagues3 estimated oral HPV incidence of 5·7 per 1000 person-months using a rinse-and-gargle method in a cohort of male and female US college students followed up for 3 months—corresponding to a 6·8% annual incidence. The similarity between these incidence estimates suggests that, to date, there is little evidence that oral HPV infection risk varies greatly across studies that differ in the composition of their study populations. * This news [...]

Charlotte Parker2013-11-08T12:51:17-07:00November, 2013|Oral Cancer News|

Oral HPV infection affects 7% of the US population

Source: www.onclive.com Author: Ben Leach Approximately 7% of Americans are infected with oral human papillomavirus (HPV), and men are 3 times as likely to be infected as women, according to an analysis that helps define a leading factor in the rise of oropharyngeal cancer. The findings of the HPV prevalence study were presented at the Multidisciplinary Head and Neck Symposium in Phoenix, Arizona, in January and concurrently published in the Journal of the American Medical Association.1 The cross-sectional study was based on samples taken from 5579 men and women between the ages of 14 to 69 years that were obtained at mobile examination centers as part of the National Health And Nutrition Examination Survey (NHANES) 2009-2010. The samples were obtained through an oral rinse and gargle, with subsequent DNA samples used to determine HPV type. Demographic data were obtained using standardized interviews. HPV prevalence in the overall study population was 6.9% (95% confidence interval [CI], 5.7%-8.3%). HPV type 16, which accounts for 90% of HPVpositive oropharyngeal squamous cell carcinomas, was the most common form, affecting 1.0% of the study population (95% CI, 0.7%-1.3%). Prevalence of HPV was significantly higher in men versus women (10.1% [95% CI, 8.3%- 12.3%] for men compared with 3.6% [95% CI, 2.6%- 5.0%] for women; P < .001]). Sexual contact was identified as a major factor in the rate of infection, with 7.5% of those who had experienced any form of sexual contact (95% CI, 6.1%-9.1%) infected, compared with 0.9% (95% CI, 0.4%-1.8%; P < .001) [...]

Oral Cancer Foundation News Team - A2012-03-14T12:09:29-07:00March, 2012|Oral Cancer News|